blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2284160

EP2284160 - PYRIMIDINE DERIVATIVE HAVING CELL-PROTECTING ACTIVITY AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.03.2014
Database last updated on 11.09.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
ZENYAKU KOGYO KABUSHIKIKAISHA
6-15, Otsuka 5-chome
Bunkyo-ku
Tokyo 112-8650 / JP
[2013/11]
Former [2011/07]For all designated states
ZENYAKU KOGYO KABUSHIKIKAISHA
2-9 Nihonbashi-Muromachi 3-chome Chuo-ku
Tokyo 103-0022 / JP
Inventor(s)01 / NAGATA, Takeshi
c/o Laboratory
of ZENYAKU KOGYO KABUSHIKIKAISHA
33-7 Ohizumi-machi 2-chome
Nerima-ku
Tokyo 178-0062 / JP
02 / SUZUKI, Toshiaki
c/o Laboratory
of ZENYAKU KOGYO KABUSHIKIKAISHA
33-7 Ohizumi-machi 2-chome
Nerima-ku
Tokyo 178-0062 / JP
03 / YOSHIMURA, Akira
c/o Laboratory
of ZENYAKU KOGYO KABUSHIKIKAISHA
33-7 Ohizumi-machi 2-chome
Nerima-ku
Tokyo 178-0062 / JP
04 / TADANO, Naoto
c/o Laboratory
of ZENYAKU KOGYO KABUSHIKIKAISHA
33-7 Ohizumi-machi 2-chome
Nerima-ku
Tokyo 178-0062 / JP
05 / MATSUNO, Toshiyuki
c/o Laboratory
of ZENYAKU KOGYO KABUSHIKIKAISHA
33-7 Ohizumi-machi 2-chome
Nerima-ku
Tokyo 178-0062 / JP
06 / SATOH, Hideki
c/o Laboratory
of ZENYAKU KOGYO KABUSHIKIKAISHA
33-7 Ohizumi-machi 2-chome
Nerima-ku
Tokyo 178-0062 / JP
07 / SAITOH, Kenichi
c/o Laboratory
of ZENYAKU KOGYO KABUSHIKIKAISHA
33-7 Ohizumi-machi 2-chome
Nerima-ku
Tokyo 178-0062 / JP
08 / OHTA, Soichi
c/o Laboratory
of ZENYAKU KOGYO KABUSHIKIKAISHA
33-7 Ohizumi-machi 2-chome
Nerima-ku
Tokyo 178-0062 / JP
 [2013/20]
Former [2011/07]01 / NAGATA, Takeshi
c/o Laboratory of ZENYAKU KOGYO KABUSHIKIKAISHA 33-7 Ohizumi-machi 2-chome Nerima-ku
Tokyo 178-0062 / JP
02 / SUZUKI, Toshiaki
c/o Laboratory of ZENYAKU KOGYO KABUSHIKIKAISHA 33-7 Ohizumi-machi 2-chome Nerima-ku
Tokyo 178-0062 / JP
03 / YOSHIMURA, Akira
c/o Laboratory of ZENYAKU KOGYO KABUSHIKIKAISHA 33-7 Ohizumi-machi 2-chome Nerima-ku
Tokyo 178-0062 / JP
04 / TADANO, Naoto
c/o Laboratory of ZENYAKU KOGYO KABUSHIKIKAISHA 33-7 Ohizumi-machi 2-chome Nerima-ku
Tokyo 178-0062 / JP
05 / MATSUNO, Toshiyuki
c/o Laboratory of ZENYAKU KOGYO KABUSHIKIKAISHA 33-7 Ohizumi-machi 2-chome Nerima-ku
Tokyo 178-0062 / JP
06 / SATOH, Hideki
c/o Laboratory of ZENYAKU KOGYO KABUSHIKIKAISHA 33-7 Ohizumi-machi 2-chome Nerima-ku
Tokyo 178-0062 / JP
07 / SAITOH, Kenichi
c/o Laboratory of ZENYAKU KOGYO KABUSHIKIKAISHA 33-7 Ohizumi-machi 2-chome Nerima-ku
Tokyo 178-0062 / JP
08 / OHTA, Soichi
c/o Laboratory of ZENYAKU KOGYO KABUSHIKIKAISHA 33-7 Ohizumi-machi 2-chome Nerima-ku
Tokyo 178-0062 / JP
Representative(s)Jönsson, Anneli, et al
Awapatent AB
Södra Hamngatan 37-41
Box 11394
404 28 Göteborg / SE
[2013/20]
Former [2011/07]Jönsson, Anneli, et al
Awapatent AB Södra Hamngatan 37-41 Box 11394
404 28 Göteborg / SE
Application number, filing date09726592.031.03.2009
[2011/07]
WO2009JP56723
Priority number, dateJP2008009436531.03.2008         Original published format: JP 2008094365
[2011/07]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009123221
Date:08.10.2009
Language:JA
[2009/41]
Type: A1 Application with search report 
No.:EP2284160
Date:16.02.2011
Language:EN
[2011/07]
Type: B1 Patent specification 
No.:EP2284160
Date:15.05.2013
Language:EN
[2013/20]
Search report(s)International search report - published on:JP08.10.2009
(Supplementary) European search report - dispatched on:EP30.03.2011
ClassificationIPC:C07D239/50, A61K31/5377, A61K31/541, A61P9/04, A61P9/10, A61P9/12, A61P17/02, A61P19/08, A61P21/00, A61P21/02, A61P25/00, A61P25/04, A61P25/08, A61P25/14
[2011/07]
CPC:
C07D239/50 (EP,US); A61P1/16 (EP); A61P1/18 (EP);
A61P13/12 (EP); A61P17/02 (EP); A61P19/08 (EP);
A61P21/00 (EP); A61P21/02 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/04 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P27/06 (EP);
A61P43/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07D239/46 (EP,US); C07D239/48 (EP,US);
C07D239/49 (EP,US); C07D401/04 (EP,US); C07D401/06 (EP,US);
C07D401/12 (EP,US); C07D403/04 (EP,US); C07D409/06 (EP,US);
C07D417/04 (EP,US); C07D495/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/07]
TitleGerman:PYRIMIDINDERIVAT MIT ZELLSCHÜTZENDER WIRKUNG UND ANWENDUNG DAVON[2011/07]
English:PYRIMIDINE DERIVATIVE HAVING CELL-PROTECTING ACTIVITY AND USE THEREOF[2011/07]
French:DÉRIVÉ DE PYRIMIDINE PRÉSENTANT UNE ACTIVITÉ DE PROTECTION CELLULAIRE ET SON UTILISATION[2011/07]
Entry into regional phase22.10.2010Translation filed 
22.10.2010National basic fee paid 
22.10.2010Search fee paid 
22.10.2010Designation fee(s) paid 
22.10.2010Examination fee paid 
Examination procedure22.10.2010Examination requested  [2011/07]
11.10.2011Amendment by applicant (claims and/or description)
31.07.2012Despatch of a communication from the examining division (Time limit: M02)
27.09.2012Reply to a communication from the examining division
03.12.2012Communication of intention to grant the patent
28.03.2013Fee for grant paid
28.03.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  31.07.2012
Opposition(s)18.02.2014No opposition filed within time limit [2014/17]
Fees paidRenewal fee
24.03.2011Renewal fee patent year 03
23.03.2012Renewal fee patent year 04
26.03.2013Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.03.2009
AT15.05.2013
BE15.05.2013
CY15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
IT15.05.2013
LT15.05.2013
LV15.05.2013
MC15.05.2013
MK15.05.2013
MT15.05.2013
NL15.05.2013
PL15.05.2013
RO15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
TR15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
[2018/30]
Former [2016/33]HU31.03.2009
AT15.05.2013
BE15.05.2013
CY15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
IT15.05.2013
LT15.05.2013
LV15.05.2013
MC15.05.2013
MT15.05.2013
NL15.05.2013
PL15.05.2013
RO15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
TR15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2016/32]HU31.03.2009
AT15.05.2013
BE15.05.2013
CY15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
IT15.05.2013
LT15.05.2013
LV15.05.2013
MC15.05.2013
MT15.05.2013
NL15.05.2013
PL15.05.2013
RO15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2016/31]AT15.05.2013
BE15.05.2013
CY15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
IT15.05.2013
LT15.05.2013
LV15.05.2013
MC15.05.2013
MT15.05.2013
NL15.05.2013
PL15.05.2013
RO15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2016/27]AT15.05.2013
BE15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
IT15.05.2013
LT15.05.2013
LV15.05.2013
MC15.05.2013
MT15.05.2013
NL15.05.2013
PL15.05.2013
RO15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2016/12]AT15.05.2013
BE15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
IT15.05.2013
LT15.05.2013
LV15.05.2013
MT15.05.2013
NL15.05.2013
PL15.05.2013
RO15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2014/14]AT15.05.2013
BE15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
IT15.05.2013
LT15.05.2013
LV15.05.2013
NL15.05.2013
PL15.05.2013
RO15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2014/11]AT15.05.2013
BE15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
IT15.05.2013
LT15.05.2013
LV15.05.2013
PL15.05.2013
RO15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2014/10]AT15.05.2013
BE15.05.2013
CZ15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
LT15.05.2013
LV15.05.2013
PL15.05.2013
SE15.05.2013
SI15.05.2013
SK15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2014/09]AT15.05.2013
BE15.05.2013
DK15.05.2013
EE15.05.2013
FI15.05.2013
HR15.05.2013
LT15.05.2013
LV15.05.2013
PL15.05.2013
SE15.05.2013
SI15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2014/06]AT15.05.2013
BE15.05.2013
FI15.05.2013
HR15.05.2013
LT15.05.2013
LV15.05.2013
PL15.05.2013
SE15.05.2013
SI15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2014/02]AT15.05.2013
FI15.05.2013
HR15.05.2013
LT15.05.2013
LV15.05.2013
PL15.05.2013
SE15.05.2013
SI15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/51]AT15.05.2013
FI15.05.2013
HR15.05.2013
LT15.05.2013
PL15.05.2013
SE15.05.2013
SI15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/50]AT15.05.2013
FI15.05.2013
LT15.05.2013
PL15.05.2013
SE15.05.2013
SI15.05.2013
BG15.08.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/49]AT15.05.2013
FI15.05.2013
LT15.05.2013
SE15.05.2013
SI15.05.2013
NO15.08.2013
GR16.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/48]AT15.05.2013
LT15.05.2013
NO15.08.2013
ES26.08.2013
IS15.09.2013
PT16.09.2013
Former [2013/47]LT15.05.2013
NO15.08.2013
PT16.09.2013
Documents cited:Search[Y]EP0372934  (WELLCOME FOUND [GB]) [Y] 1-16* page 41, line 55 - page 43, line 55; example -; claim - *;
 [Y]WO02098864  (HOFFMANN LA ROCHE [CH]) [Y] 1-16 * page 2, line 17 - page 3, line 23; example -; claim - *
International search[A]JPS5049288  (THOMAE GMBH DR K);
 [A]JP2001519416  (KRENITSKY PHARMACEUTICAIS, INC.);
 [X]  - JOHN E. CABAJ ET AL., "Bromine-Mediated Addition of Nucleophiles to the Electron-Rich Pyrimidine Subunit of Tirilazad", THE JOURNAL OF ORGANIC CHEMISTRY, (1994), vol. 59, no. 17, pages 5090 - 5092, XP002275310

DOI:   http://dx.doi.org/10.1021/jo00096a068
 [X]  - W. C. J. ROSS ET AL., "Some Derivatives of 4- Styrylpyrimidine", JOURNAL OF THE CHEMICAL SOCIETY, (1948), pages 1128 - 1135, XP008146467
by applicant   - HIRSCH T ET AL., "The apoptosis-necrosis paradox", ONCOGENE, (1997), vol. 15, pages 1573 - 1581
    - KROEMER G ET AL., "The mitochondorial death/life regulator in apoptosis and necrosis", ANNU REV PHYSIOL, (1998), vol. 60, pages 619 - 642
    - MARTIN L, "Neuronal cell death in nervous system development, disease, and injury", INT J MOL MED, (2001), vol. 7, pages 455 - 478
    - LUKASZEVICZ A ET AL., "High sensitivity of protoplasmic cortical astroglia to focal ischemia", J CEREB BLOOD FLOW METAB, (2002), vol. 22, pages 289 - 298
    - GARCIA J ET AL., "Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat", AM PATHO, (1993), vol. 142, pages 623 - 635
    - MARTIN L ET AL., "Hypoxia-ischemia cause abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum", ANN NEUROL, (1997), vol. 42, pages 335 - 348
    - LIU D ET AL., "Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain", MOL BRAIN RES, (1999), vol. 68, pages 29 - 41
    - MARAGAKIS NJ; ROTHSTEIN JD, "Mechanisms of disease: astrocytes in neurodegenerative disease", NAT CLIN PRAC NEUROL, (2006), vol. 2, pages 679 - 689
    - COTTER DR ET AL., "Glial cell abnormalities in major psychiatric disorders: the evidence and implications", BRAIN RES BULL, (2001), vol. 55, pages 585 - 595
    - WARDLAW JM ET AL., "Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke", LANCET, (1997), vol. 350, pages 607 - 614
    - FLAMM E ET AL., "Free radicals in cerebral ischemia", STROKE, (1978), vol. 9, pages 445 - 447
    - CHOI D, "Glutamate neurotoxicity and diseases of the nervous system", NEURON, (1988), vol. 1, pages 623 - 634
    - KRISTIAN T; SIESJO B, "Calcium in ischemic cell death", STROKE, (1998), vol. 29, pages 705 - 718
    - BLANDINI F ET AL., "Glutamate and Parkinson's disease", MOL NEUROBIOL, (1996), vol. 12, pages 73 - 94
    - FARBER NB ET AL., "The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease", PROG BRAIN RES, (1998), vol. 116, pages 421 - 437
    - KIEBURTZ K, "Antiglutamate therapies in Huntington's disease", J NEURAL TRANSM SUPPL, (1999), vol. 55, pages 97 - 102
    - KEMP JA; MCKERNAN RM, "NMDA receptor pathways as drug targets", NAT NEUROSCI, (2002), vol. 5, pages 1039 - 1042
    - VAN DEN BOSCH L ET AL., "The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis", BIOCHEM BIOPHYS ACTA, (2006), vol. 1762, pages 1068 - 1082
    - "Pharmaceutical Salts", J.PHARM.SCI., (1977), vol. 66, pages 1 - 19
    - T. HIGUCHI; V. STELLA, "Pro-drugs as Novel Delivery Systems", A.C.S. SYMPOSIUM SERIES, vol. 14
    - S. G. SYDSERFF ET AL., BRITISH J. PHARMACOL, (2002), vol. 135
    - TAKEO S ET AL., STROKE, (1992), vol. 23, pages 62 - 68
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.